Market Tracker

09/27 4:42pm ET

Emergent BioSolutions Inc (NYSE:EBS)

28.50
Delayed Data
As of 4:02pm ET
 +0.40 / +1.42%
Today’s Change
25.51
Today|||52-Week Range
41.91
-24.58%
Year-to-Date

Today’s Trading

Previous close28.10
Today’s open28.10
Day’s range27.98 - 28.50
Volume233,936
Average volume (3 months)673,603
Market cap$1.1B
Dividend yield--
Data as of 4:02pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-28.90%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+16.14%
P/E ratio19.9
Price/Sales3.62
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...-0.09-1.08%
AERIAerie Pharmaceutical...+1.36+3.46%
MGNXMacroGenics Inc+1.09+3.51%
DERMDermira Inc+0.32+0.94%
Data as of 4:00pm ET, 09/27/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts